$2.16
0.03[1.41%]
At close: May 2
$2.07
-0.0900[-4.17%]
After Hours: 7:03AM EDT
PharmaCyte Biotech
(NASDAQ:PMCB)PharmaCyte Biotech Stock (NASDAQ:PMCB), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
No data available to display
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|
FAQ
What is the most recent guidance for PharmaCyte Biotech (PMCB)?
The last reported Earnings numbers were from July 11, 2022 for the full year 2022 and was for an earnings per share guidance in the range of $-0.27 and $-0.27 versus the estimated EPS of $-0.24.
Browse guidance and forecast on all stocks.